NO20000811L - FremgangsmÕte for valg av medikament - Google Patents

FremgangsmÕte for valg av medikament

Info

Publication number
NO20000811L
NO20000811L NO20000811A NO20000811A NO20000811L NO 20000811 L NO20000811 L NO 20000811L NO 20000811 A NO20000811 A NO 20000811A NO 20000811 A NO20000811 A NO 20000811A NO 20000811 L NO20000811 L NO 20000811L
Authority
NO
Norway
Prior art keywords
library
members
identified
selecting
amino acid
Prior art date
Application number
NO20000811A
Other languages
English (en)
Other versions
NO20000811D0 (no
Inventor
Julian Cockbain
Henry R Wolfe
Original Assignee
Nycomed Imaging As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Imaging As filed Critical Nycomed Imaging As
Publication of NO20000811D0 publication Critical patent/NO20000811D0/no
Publication of NO20000811L publication Critical patent/NO20000811L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B30/00Methods of screening libraries
    • C40B30/04Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C07K1/047Simultaneous synthesis of different peptide species; Peptide libraries
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6845Methods of identifying protein-protein interactions in protein mixtures
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/24Assays involving biological materials from specific organisms or of a specific nature from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • G01N2333/245Escherichia (G)

Abstract

Det er beskrevet en fremgangsmåte for valgt en kandidatmedikament-forbindelse, idet fremgangsmåten omfatter: i) identifisering av et utgangsoligopeptid som har en bindingsaffinitet for en celleoverflate eller annet reseptorsete; ii) dannelse av en mengde homologe oligopeptider som har enkeltsete aminosyre-modifikasjoner relativt til nevnte utgangs oligopeptid; iii) identifisering av komponentene til nevnte utgangsoligopeptid ansvarlig forden sekundære strukturen derav; iv) for modifisering av seter identifisert i trinn (ii) selektering av et sett aminosyrer; v) for komponenter identifisert i trinn (iii) selektering av minst en ikke-naturlig aminosyre som etterligner den sekundære strukturen til komponenten; vi) dannelse av et første kombinatorisk bibliotek av oligopeptider som har det nevnte identifiserte modifikasjonssete aminosyreresidier som korresponderer med nevnte selekterte sett av aminosyrer; vii) identifisering av medlemmer av nevnte første bibliotek som har en bindingsaffinitetverdi over et forutbestemt minimum og dannelse av et ytterligere kombinatorisk bibliotek av oligopeptider som har medlemmer som ikke er tilstede i første bibliotek, og identifisering åv medlemmene til nevnte ytterligere bibliotek som har forbedrede bindingsaffinitetsverdier i forhold til de identifiserte medlemmene av nevnte første bibliotek og med den forutsetningen at minst av nevnte første og ytterligere bibliotek inneholder oligopeptider inneholdende residier av nevnte ikke-naturlige aminosyre eller syrer; og (viii) selektering fra de identifiserte medlemmene av nevnte bibliotek en medikamentkandidat.
NO20000811A 1997-08-20 2000-02-18 FremgangsmÕte for valg av medikament NO20000811L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9717652.3A GB9717652D0 (en) 1997-08-20 1997-08-20 Method
PCT/GB1998/002504 WO1999009416A2 (en) 1997-08-20 1998-08-20 Method of drug selection

Publications (2)

Publication Number Publication Date
NO20000811D0 NO20000811D0 (no) 2000-02-18
NO20000811L true NO20000811L (no) 2000-04-12

Family

ID=10817781

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000811A NO20000811L (no) 1997-08-20 2000-02-18 FremgangsmÕte for valg av medikament

Country Status (7)

Country Link
EP (1) EP1005655A2 (no)
JP (1) JP2001516029A (no)
AU (2) AU8817398A (no)
CA (1) CA2300903A1 (no)
GB (1) GB9717652D0 (no)
NO (1) NO20000811L (no)
WO (2) WO1999009416A2 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9809776D0 (en) 1998-05-07 1998-07-08 Nycomed Imaging As Method
GB9809782D0 (en) * 1998-05-07 1998-07-08 Nycomed Imaging As Method
GB9809780D0 (en) * 1998-05-07 1998-07-08 Nycomed Imaging As Method
WO2008106429A2 (en) * 2007-02-26 2008-09-04 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of heart failure and other disorders
CA2707840A1 (en) 2007-08-20 2009-02-26 Allozyne, Inc. Amino acid substituted molecules
US10166279B2 (en) 2013-02-20 2019-01-01 Bergen Teknologioverføring Vaccine
CN113195520A (zh) * 2018-08-24 2021-07-30 挪威西部创新股份有限公司 作为抗腹泻疫苗抗原的热稳定肠毒素突变体

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5075211A (en) * 1986-03-26 1991-12-24 Genetic Systems Corporation Synthetic antigen for the detection of AIDS-related disease
US4965343A (en) * 1988-01-28 1990-10-23 Hoffmann-La Roche Inc. Method of peptide synthesis
JPH0768271B2 (ja) * 1989-08-31 1995-07-26 三菱化学株式会社 ヒトオステオカルシンの製造法
CS89491A3 (en) * 1990-04-09 1992-01-15 Chugai Pharmaceutical Co Ltd Hybrid calcitonin
US5723286A (en) * 1990-06-20 1998-03-03 Affymax Technologies N.V. Peptide library and screening systems
US5824483A (en) * 1994-05-18 1998-10-20 Pence Inc. Conformationally-restricted combinatiorial library composition and method
US5911997A (en) * 1995-06-07 1999-06-15 Connetics Corporation Relaxin-like factor and methods and uses thereof
EP0868427B1 (en) * 1995-12-18 2003-05-14 Praecis Pharmaceuticals Incorporated Methods for identifying compounds that bind to a target

Also Published As

Publication number Publication date
GB9717652D0 (en) 1997-10-22
AU8817398A (en) 1999-03-08
NO20000811D0 (no) 2000-02-18
EP1005655A2 (en) 2000-06-07
CA2300903A1 (en) 1999-02-25
JP2001516029A (ja) 2001-09-25
WO1999009417A9 (en) 1999-05-27
WO1999009416A3 (en) 1999-10-21
WO1999009416A2 (en) 1999-02-25
WO1999009417A2 (en) 1999-02-25
AU8816898A (en) 1999-03-08
WO1999009417A3 (en) 1999-08-12

Similar Documents

Publication Publication Date Title
Geysen et al. Screening chemically synthesized peptide libraries for biologically-relevant molecules
Slootstra et al. Structural aspects of antibody-antigen interaction revealed through small random peptide libraries
NO20000811L (no) FremgangsmÕte for valg av medikament
ATE234268T1 (de) Synthese von n-substituierten oligomeren
DE69623970T2 (de) Formulierung von d-threo methylphenidat mit verzögerter freisetzung
DK0751950T3 (da) Fremgangsmåde til identifikation af elementer af kombinatoriske biblioteker
CA2224086A1 (en) Conformationally-restricted combinatorial library composition and method
DE60035860D1 (de) Rationale auswahl von mutmasslichen peptiden aus identifizierten nukleotid- beziehungsweise peptidsequenzen
CA2313380A1 (en) Method for creating polynucleotide and polypeptide sequences
DK0868427T3 (da) Fremgangsmåder til at idenficere forbindelser, der binder til et mål
ATE160223T1 (de) Kombinatorische bibliotheken und verfahren zu ihrer verwendung
ATE311443T1 (de) Methoden zur durchforstung (screenen) von proteinen
EP0831397A3 (en) A method and apparatus for operation control of memories
IL143123A0 (en) Methods for the preparation of nucleic acid and polypeptide libraries and uses thereof
WO2000007017A3 (en) Method of high-throughput screening
WO2001050355A3 (en) Computer predictions of molecules
CA2173102A1 (en) Dna sequence coding for a bmp receptor
WO2001037147A3 (en) Apparatus and method for structure-based prediction of amino acid sequences
WO2002093297A3 (en) Methods for high-throughput screening and computer modelling of pharmaceutical compounds
GB9816514D0 (en) Novel method
Hirabayashi et al. Identification of peptides mimicking the antigenicity and immunogenicity of conformational epitopes on Japanese encephalitis virus protein using synthetic peptide libraries
CA2386607A1 (en) Method for identifying binding partners with position-specific arrays
CA2280752A1 (en) Drug screen targeting lipoprotein-membrane anchorage
ATE290691T1 (de) Verfahren zur identifizierung von leitstrukturen oder aktiven verbindungen
EP1176512A3 (en) Test scripts